Lundmark, F.; Abouzayed, A.; Mitran, B.; Rinne, S.S.; Varasteh, Z.; Larhed, M.; Tolmachev, V.; Rosenström, U.; Orlova, A.
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model. Pharmaceutics 2020, 12, 614.
https://doi.org/10.3390/pharmaceutics12070614
AMA Style
Lundmark F, Abouzayed A, Mitran B, Rinne SS, Varasteh Z, Larhed M, Tolmachev V, Rosenström U, Orlova A.
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model. Pharmaceutics. 2020; 12(7):614.
https://doi.org/10.3390/pharmaceutics12070614
Chicago/Turabian Style
Lundmark, Fanny, Ayman Abouzayed, Bogdan Mitran, Sara S. Rinne, Zohreh Varasteh, Mats Larhed, Vladimir Tolmachev, Ulrika Rosenström, and Anna Orlova.
2020. "Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model" Pharmaceutics 12, no. 7: 614.
https://doi.org/10.3390/pharmaceutics12070614
APA Style
Lundmark, F., Abouzayed, A., Mitran, B., Rinne, S. S., Varasteh, Z., Larhed, M., Tolmachev, V., Rosenström, U., & Orlova, A.
(2020). Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model. Pharmaceutics, 12(7), 614.
https://doi.org/10.3390/pharmaceutics12070614